evoke semaglutide Novo Nordisk announces topline results from the and Evoke+ trials of in early AD Evoke and Evoke+: Oral Semaglutide

Metsera is exploring a range of weekly doses for its Phase 2b trials in obesity (with or without T2D separately), and looks to find the optimized weekly dose for both efficacy/tolerability

doi: 10.1210/edrv-16-1-3

Can genetic testing help me understand how I'll respond to semaglutide

Moreover, thyroid hormones have been shown to influence calcium homeostasis and flux responsible for excitation and contractility, with L-Thyroxine and Triiodothyronine modulating its pharmacological control and secretion

Long-term impacts of interventions on health outcomes and patient adherence can be explored as well as the importance of hydration during GLP-1 RA therapy